Krystal Biotech, Inc. (KRYS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 50M 100M 150M Q3 '22: 0 Q4 '22: 0 Q1 '23: 0 Q2 '23: 0 Q3 '23: 8.6M Q4 '23: 42.1M Q1 '24: 45.2M Q2 '24: 70.3M Q3 '24: 83.8M Q4 '24: 91.1M Q1 '25: 88.2M Q2 '25: 96M Q3 '25: 97.8M Q4 '25: 107.1M Q1 '26: 116.4M Q2 '26: 119.2M Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '16: -322K Q4 '16: -620K Q1 '17: -465K Q2 '17: -715K Q3 '17: -2.1M Q4 '17: -1.5M Q1 '18: -2.3M Q2 '18: -2.4M Q3 '18: -3M Q4 '18: -4.2M Q1 '19: -4.7M Q2 '19: -5.9M Q3 '19: -5.3M Q4 '19: -6.2M Q1 '20: -5.9M Q2 '20: -7M Q3 '20: -9.7M Q4 '20: -10.4M Q1 '21: -14.4M Q2 '21: -16.4M Q3 '21: -15.7M Q4 '21: -21.9M Q1 '22: -50.2M Q2 '22: -28.8M Q3 '22: -31.5M Q4 '22: -34.8M Q1 '23: -48.8M Q2 '23: -38M Q3 '23: -26M Q4 '23: 3.2M Q1 '24: -6.7M Q2 '24: 8.6M Q3 '24: 22.5M Q4 '24: 41.4M Q1 '25: 36.3M Q2 '25: 39.4M Q3 '25: 41.4M Q4 '25: 44.3M Q1 '26: 53.7M Q2 '26: 58.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-60M -30M 0 30M 60M 90M Q3 '16: -322K Q4 '16: -627K Q1 '17: -494K Q2 '17: -759K Q3 '17: -5.3M Q4 '17: -1.4M Q1 '18: -2.1M Q2 '18: -2.3M Q3 '18: -2.8M Q4 '18: -3.7M Q1 '19: -4.1M Q2 '19: -5.3M Q3 '19: -4.3M Q4 '19: -5.4M Q1 '20: -5.3M Q2 '20: -6.8M Q3 '20: -9.6M Q4 '20: -10.4M Q1 '21: -15.8M Q2 '21: -16.4M Q3 '21: -15.6M Q4 '21: -21.8M Q1 '22: -50M Q2 '22: -28.1M Q3 '22: -29.9M Q4 '22: -32.1M Q1 '23: -45.3M Q2 '23: -33.2M Q3 '23: 80.7M Q4 '23: 8.7M Q1 '24: 932K Q2 '24: 15.6M Q3 '24: 27.2M Q4 '24: 45.5M Q1 '25: 35.7M Q2 '25: 38.3M Q3 '25: 79.4M Q4 '25: 51.4M Q1 '26: 55.9M Q2 '26: 54.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-60M -30M 0 30M 60M 90M Q4 '16: -861K Q1 '17: -257K Q2 '17: -408K Q3 '17: -1.1M Q4 '17: -2.1M Q1 '18: -2.4M Q2 '18: -1.6M Q3 '18: -1.9M Q4 '18: -3.5M Q1 '19: -3.2M Q2 '19: -4.2M Q3 '19: -4.3M Q4 '19: -7M Q1 '20: -6.2M Q2 '20: -5.1M Q3 '20: -6.8M Q4 '20: -8M Q1 '21: -9.7M Q2 '21: -10.1M Q3 '21: -7.3M Q4 '21: -20.9M Q1 '22: -15.5M Q2 '22: -43.1M Q3 '22: -19.7M Q4 '22: -22.3M Q1 '23: -26.2M Q2 '23: -34.2M Q3 '23: -21.2M Q4 '23: -7.2M Q1 '24: 15.9M Q2 '24: -4.2M Q3 '24: 58.9M Q4 '24: 52.8M Q1 '25: 31M Q2 '25: 52.7M Q3 '25: 39.7M Q4 '25: 77.5M Q1 '26: 80.4M Q2 '26: 74.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-90M -60M -30M 0 30M 60M 90M Q4 '16: -870K Q1 '17: -264K Q2 '17: -440K Q3 '17: -1.1M Q4 '17: -2.3M Q3 '18: -2.8M Q4 '18: -4.8M Q1 '19: -4.9M Q2 '19: -5.4M Q3 '19: -5.4M Q4 '19: -9.3M Q1 '20: -7.7M Q2 '20: -7M Q3 '20: -11M Q4 '20: -15.2M Q1 '21: -12.1M Q2 '21: -14.1M Q3 '21: -28.2M Q4 '21: -61.8M Q1 '22: -32.7M Q2 '22: -59.6M Q3 '22: -33.7M Q4 '22: -27.5M Q1 '23: -31.5M Q2 '23: -37M Q3 '23: -23M Q4 '23: -9.1M Q1 '24: 14.6M Q2 '24: -5.3M Q3 '24: 57.8M Q4 '24: 52M Q1 '25: 24.8M Q2 '25: 50.8M Q3 '25: 38M Q4 '25: 75.4M Q1 '26: 73.2M Q2 '26: 71.2M Q1 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '20: 18.4M Q3 '20: 19.7M Q1 '21: 21.3M Q2 '21: 22.2M Q3 '21: 22.2M Q1 '22: 25.1M Q2 '22: 25.5M Q3 '22: 25.6M Q1 '23: 25.7M Q2 '23: 26.7M Q3 '23: 28.9M Q1 '24: 29.3M Q2 '24: 29.6M Q3 '24: 29.9M Q1 '25: 29.9M Q2 '25: 29.7M Q3 '25: 29.8M Q1 '26: 30.5M Q2 '26: 30.7M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -3.00 0.00 3.00 6.00 9.00 Q4 '17: -1.48 Q1 '18: -1.55 Q2 '18: -1.55 Q3 '18: -0.55 Q4 '18: -0.97 Q1 '19: -1.05 Q2 '19: -1.20 Q3 '19: -1.19 Q4 '19: -1.22 Q1 '20: -1.24 Q2 '20: -1.24 Q3 '20: -1.48 Q4 '20: -1.70 Q1 '21: -2.13 Q2 '21: -2.50 Q3 '21: -2.71 Q4 '21: -3.13 Q1 '22: -4.38 Q2 '22: -4.74 Q3 '22: -5.21 Q4 '22: -5.51 Q1 '23: -5.28 Q2 '23: -5.43 Q3 '23: -1.47 Q4 '23: 0.39 Q1 '24: 2.18 Q2 '24: 3.96 Q3 '24: 2.08 Q4 '24: 3.00 Q1 '25: 4.17 Q2 '25: 4.93 Q3 '25: 6.68 Q4 '25: 6.85 Q1 '26: 7.48 Q2 '26: 7.98 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.